Trusted byOracleSnowflakeCloudflareLinkedInGoogleSalesforce★★★★★4.8/5 on G2
Mindera Health Partners with National Psoriasis Foundation to Advance Precision Medicine in Psoriasis Treatment
Nov 19, 2024
Contract Type
partnership
San DiegoBiotechnology
Description
Mindera Health, a leader in precision medicine for dermatological conditions, has announced a strategic partnership with the National Psoriasis Foundation (NPF), aiming to drive awareness of personalized medicine and accelerate the adoption of innovative technology to improve patient outcomes nationwide. The partnership represents a pivotal moment in psoriasis care, bringing precision medicine to psoriasis patients.
Company Information
Company
Mindera Health
Location
5795 KEARNEY VILLA ROAD
San Diego, California, United States
About
Mindera Health™ is commercializing scalable extraction technology and data analysis to report a patient’s individual transcriptomic data. Mindera’s technology creates Dermal Intelligence™, actionable information for payers, providers and patients. The company’s flagship test, Mind.Px, uses both a dermal biomarker patch and Machine Learning to determine a patient’s receptivity to very expensive psoriasis biologics. This information is valuable to payers, who can save thousands of dollars per biologic patient using Mind.Px at the outset of prescription. Mind.Px is the first test in a large planned product pipeline, including psoriatic arthritis and eczema biologic receptivity.